Meeting abstract
CARDIOEMBOLIC STROKE
Hrvoje Budinčević
orcid.org/0000-0002-0184-8949
; Klinička bolnica „Sveti Duh“, Klinika za neurologiju, Zavod za cerebrovaskularne bolesti i intenzivnu neurologiju, Zagreb, Hrvatska; Medicinski fakultet Sveučilišta J. J. Strossmayer u Osijeku, Hrvatska
Dorotea Vidaković
; Medicinski fakultet Sveučilišta J. J. Strossmayer u Osijeku, Hrvatska
Abstract
Stroke is one of the leading causes of disability and mortality in the world. Cardioembolic stroke ac-counts for 30% of all ischemic strokes. Cardioembolic strokes are most commonly caused by atrial fi-brillation and are associated with increased disability, mortality and recurrence. The clinical picture of an embolic stroke is usually presented by the sudden onset of symptoms with maximal intensity, and the rapid recovery from symptoms may also indicate this type of stroke. In the secondary prevention of this type of stroke, anticoagulant therapy has a leading role. In recent years, new or direct oral antico-agulants such as dabigatran, rivaroxaban, apixaban and edoxaban have been available in the prevention of stroke caused by atrial fibrillation.
Keywords
stroke; prevention; anticoagulant therapy
Hrčak ID:
232960
URI
Publication date:
31.12.2019.
Visits: 1.131 *